TokenPost·
Anthropic Says Mithril Drug Reached Animal Testing With AI Support
The potential treatment targets a rare muscle-wasting disease and could enter human trials as early as late 2028 if further experiments go well.
More news
- TokenPostOne in Five Philippine Survey Respondents Use Stablecoins for Cross-Border Payments
- TokenPostSanDisk Rises More Than 13% as U.S. Storage Stocks Advance
- TokenPostTel-Aviv Stock Exchange Q3 Profit Rises 37% to NIS 68.3 Million
- CryptopolitanSuperMicro to ship H15 servers powered by AMD
- TokenPostRipple Deletes Qivalis Post and Blog Article After Commentator's Criticism
- TokenPostbStocks Sets a Record With $1.5 Billion in Assets Under Management